The United Laboratories International Holdings Limited provided group earnings guidance for the year ended December 31, 2013. The group's annual results for the year ended December 31, 2013 is expected to record a substantial decrease in profit as compared with that of last year. The decrease in profit is mainly attributable to the following reasons: Decrease in gain on fair value change of embedded derivative components of convertible bonds as the company repaid the convertible bonds substantially during the year; and Write-off of all production facilities located in Chengdu factory to consolidate it with the production in Inner Mongolia factory in order to enhance the scale of production, reduce the cost of production and enhance efficiency as a whole.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.24 HKD | -0.24% |
|
-5.50% | +17.55% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.55% | 191.75Cr | |
+55.32% | 82TCr | |
+44.05% | 64TCr | |
-6.75% | 35TCr | |
+13.56% | 31TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr | |
-2.81% | 16TCr |
- Stock Market
- Equities
- 3933 Stock
- News The United Laboratories International Holdings Limited
- The United Laboratories International Holdings Limited Provides Group Earnings Guidance for the Year Ended December 31, 2013